Authors' reply-A sensitivity analysis of the RAPIDO clinical trial.

Dijkstra, E A; Zwart, W H; Putter, H; Marijnen, C A M; Nilsson, P J; van de Velde, C J H; van Etten, B; Hospers, G A P; Glimelius, B

Dijkstra, E A; Zwart, W H; Putter, H; Marijnen, C A M; Nilsson, P J; van de Velde, C J H; van Etten, B; Hospers, G A P; Glimelius, B.

Afiliação

Dijkstra EA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: e.a.dijkstra@umcg.nl.
Zwart WH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Putter H; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Nilsson PJ; Department of Surgery, Karolinska University Hospital, Stockholm, Sweden.
van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
van Etten B; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Ann Oncol ; 34(4): 446-447, 2023 04.

Article em En | MEDLINE | ID: mdl-36581138

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google